451 - 475 of 6514 Results
Title
Year
- Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson Disease2020OPENTitle: Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson DiseaseJournal Name: World NeurosurgeryPublisher: Elsevier BVVol: 139Issue #:Start Page: e784End Page: e791Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.wneu.2020.04.160Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S187887502030869XCitation Count: 2
-
OPENTitle: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeysJournal Name: eBioMedicinePublisher: Elsevier BVVol: 59Issue #:Start Page: 102944End Page: 102944Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944Best OA location URL: http://www.thelancet.com/article/S2352396420303200/pdfCitation Count: 73
-
OPENTitle: Not only loud but also intelligibleJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 24Issue #:Start Page: 100456End Page: 100456Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2020.100456Best OA location URL: http://www.thelancet.com/article/S2589537020302005/pdfCitation Count: 2
-
OPENTitle: Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine LearningJournal Name: iSciencePublisher: Elsevier BVVol: 23Issue #: 2Start Page: 100804End Page: 100804Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2019.100804Best OA location URL: https://doi.org/10.1016/j.isci.2019.100804Citation Count: 21
-
OPENTitle: Deep brain stimulation of the ventralis oralis anterior thalamic nucleus is effective for dystonic tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 8End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.040Best OA location URL: http://hdl.handle.net/11380/1268601Citation Count: 8
-
OPENTitle: Longitudinal association between dopamine agonists and weight in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 158End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.037Best OA location URL: http://www.prd-journal.com/article/S1353802020307690/pdfCitation Count: 8
-
OPENTitle: Multimodal assessment of nigrosomal degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 102End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021Best OA location URL: https://arxiv.org/pdf/2009.01378Citation Count: 20
-
OPENTitle: Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 73End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.019Best OA location URL: https://arxiv.org/pdf/2201.09654Citation Count: 20
-
OPENTitle: Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and “OFF” episodesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 110End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.08.028Best OA location URL: http://www.prd-journal.com/article/S1353802020306945/pdfCitation Count: 16
-
OPENTitle: Anxiety in Parkinson's disease is associated with changes in the brain fear circuitJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 89End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.020Best OA location URL: http://www.prd-journal.com/article/S1353802020307343/pdfCitation Count: 33
-
OPENTitle: Robust and facile purification of full-length, untagged human Nedd4 as a recombinant protein from Escherichia coliJournal Name: Protein Expression and PurificationPublisher: Elsevier BVVol: 173Issue #:Start Page: 105649End Page: 105649Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.pep.2020.105649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8494286Citation Count: 4
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 29
-
OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://www.prd-journal.com/article/S1353802020300973/pdfCitation Count: 54
-
OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 42
-
OPENTitle: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7686230Citation Count: 17
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 22
-
OPENTitle: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case reportJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 36End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085430Citation Count: 14
-
OPENTitle: The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 97End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7415666Citation Count: 62
-
OPENTitle: Genetic characterization of Parkinson's disease patients in Ecuador and ColombiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.005Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10236935/pdf/nihms-1900454.pdfCitation Count: 8
-
OPENTitle: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data SetJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 29Issue #: s1Start Page: 415End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617723005507Citation Count: 0
-
OPENTitle: Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithmsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 22426End Page: 22426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-49617-wBest OA location URL: https://www.nature.com/articles/s41598-023-49617-w.pdfCitation Count: 8
-
OPENTitle: α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept studyJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 6Start Page: fcad285End Page: fcad285Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad285Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcad285/52454987/fcad285.pdfCitation Count: 15
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page: eadi8716End Page: eadi8716Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://doi.org/10.1126/sciadv.adi8716Citation Count: 201
-
OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page: eadk6191End Page: eadk6191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://doi.org/10.1126/sciadv.adk6191Citation Count: 43
-
OPENTitle: Erythroid Differentiation Dependent Interaction of VPS13A with XK at the Plasma Membrane of K562 CellsJournal Name: ContactPublisher: SAGE PublicationsVol: 6Issue #:Start Page: 25152564231215133End Page: 25152564231215133Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1177/25152564231215133Best OA location URL: https://doi.org/10.1177/25152564231215133Citation Count: 10